The innovative use of anti-PDGFRL antibody-conjugated liposomes in colorectal cancer treatment represents a significant advancement in drug delivery systems. By specifically targeting the PDGFRL receptor, these liposomes not only ensure a higher bioavailability of therapeutic agents but also improve their selectivity towards cancer cells, minimizing off-target effects. This targeted approach facilitates the endocytosis of drugs into tumor cells, significantly enhancing their anti-tumor activity and potentially leading to more effective treatment outcomes for patients suffering from colorectal cancer.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-3930z | Mouse Anti-PDGFRL Recombinant Antibody (clone 37B7) | WB, IP, IF, ELISA | Mouse IgG1, κ |
There are currently no Customer reviews or questions for VS-1024-FY148. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.